Daewoong Pharmaceutical’s first shipment from new Nabota Factory
Daewoong Pharmaceutical(CEO Jong-Wook Lee) has first shipped the item which was first manufactured at ‘Nabota’ Factory 2 on the 20th. Nabota Factory 2 has acquired KGMP approval from the Ministry of Food and Drug Safety(MFDS) and successfully completed the U.S. FDA onsite inspection last month.
...Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.